Acetoglyceride

Acetoglyceride (Acetylated Monoglyceride): A Comprehensive Reference

1. Identity, Nomenclature, and Chemical Description

Acetoglyceride is the collective name for a class of lipid compounds formed when one or more of the free hydroxyl groups on a glycerol backbone—already esterified with a long-chain fatty acid—are further esterified with acetic acid. Synonyms include acetylated mono- and diglycerides, acetic acid esters of mono- and diglycerides, acetofats, and, in regulatory nomenclature, acetic acid and fatty acid esters of glycerol; the chemical description is a product consisting of mixed glycerol esters of acetic acid and fatty acids. The term is therefore not a single molecular entity but a family of structurally related compounds whose properties vary with the chain length and degree of unsaturation of the fatty acid moiety and with the number of hydroxyl groups that have been acetylated.

Chemically, acetylated monoglycerides are mixtures derived from monoglycerides that have been modified with one or two acetyl groups; the fatty acid side chains of the monoglyceride can be varied to give differing properties. Acetylated mono- and diglycerides contain mono- and some di-esters of fatty acids with glycerol which is itself partially acetylated; the product may contain free glycerol and free fatty acids.

Chemically, acetylated monoglycerides (AMG) are acetic acid esters of monoglycerides whose properties depend on the composition of the monoglyceride and the degree of acetylation. The degree of acetylation is the percentage of hydroxyl (—OH) linkages on the monoglyceride and diglyceride molecules that are converted to esters via acetylation; each monoglyceride molecule has two hydroxyl groups available for conversion, and each diglyceride molecule has one hydroxyl group available for conversion. Higher degrees of acetylation lead to higher flexibility and less rigidity.

The most studied individual members of this class are acetostearin (acetylated monoglyceride derived from stearic acid, a saturated C18 fatty acid) and acetoolein (derived from oleic acid, an unsaturated C18 fatty acid). Acetylated monoglycerides vary in consistency from liquids to solids and are white to pale yellow in colour. They may have an acetic acid odour.

Acetylated monoglycerides (AMG) are non-ionic surfactants widely used in baking and other food formulations; chemically, they are acetic acid esters of monoglycerides whose properties depend on the composition of the monoglyceride and the degree of acetylation. AMG is a nonionic and fat-soluble surfactant; its stable alpha crystalline structure is responsible for its emulsifying properties mainly at higher temperatures, and it has a low polarity and hydrophilic–lipophilic balance (HLB) of 1.5, indicating low emulsifying capacity.

As a food additive in the European Union, the acetic acid esters of mono- and diglycerides of fatty acids carry the designation E472a. The International Numbering System (INS) designation is 472a, and the functional class is food additive / emulsifier. In the United States, acetylated monoglycerides are regulated under the Code of Federal Regulations as a permitted food additive under 21 CFR 172.828. The food additive acetylated monoglycerides may be safely used in or on food in accordance with prescribed conditions, one of which is the interesterification of edible fats with triacetin in the presence of catalytic agents that are not food additives or are otherwise authorized.

2. Natural Sources and Raw Material Derivation

Acetoglycerides do not occur in significant amounts as naturally isolated constituents in plants or animals. They are produced industrially from edible fats and oils—a wide variety of vegetable and animal lipid feedstocks has been reported. Sources of triglycerides used for producing the monoglyceride and acetylated monoglyceride include hydrogenated palm oil, hydrogenated soybean oil, hydrogenated cottonseed oil, refined palm oil, refined sunflower oil, refined cottonseed oil, hydrogenated coconut oil, and refined canola oil. Animal fats have also been used: the most preferred source in some formulations has been acetylated monoglycerides produced from lard, such products being commercially available, for instance under the brand name MYVACET from the Distillation Products Industries Division of Eastman Kodak Co., or under the brand names DERMATEX and SKINTEX.

The fundamental raw material relationship is that acetoglycerides are entirely derived from ordinary dietary components: glycerol, long-chain fatty acids (themselves derived from natural fats), and acetic acid. The long-chain fatty acids in triglycerides may be replaced with one or more acetic acid groups to produce mono- or diacetins (acetoglycerides), which are resistant to changes in consistency, heat damage, and oxidative rancidity.

3. Synthesis and Common Preparations

Two principal manufacturing routes for food-grade acetoglycerides are recognized in regulatory and technical literature:

• Interesterification: Acetoglycerides are normally produced from monoacylglycerols and acetic anhydride or by interesterification of monoacylglycerols with triacetin. In this approach, a conventional edible fat is reacted with triacetin (glycerol triacetate) in the presence of a catalyst, typically a sodium alkoxide, to redistribute the acyl groups across glycerol molecules, yielding a mixture of acetylated glycerides. Residual triacetin and catalyst must be removed by molecular distillation or steam stripping before the product is approved for food use.
• Direct acetylation: Alternatively, AMG is produced by direct acetylation of edible monoglycerides with acetic anhydride without the use of a catalyst. In both cases, the edible food-approved process is followed by molecular distillation or steam stripping, or by vacuum distillation to remove acetic acid, acetic anhydride, and triacetin.

The degree of acetylation governs physical state and functional properties. Fully acetylated monoglycerides prepared from unsaturated monoglycerides are liquids at room temperature; in this context, "fully acetylated" is intended to mean having a minimum acetylation of about 96%. The application for which E472a is intended will determine the degree of acetylation, which can be achieved by varying the fatty acid profile of the fat or monoglyceride and the quantity of acetic anhydride or triacetin used.

Commercial acetoglyceride products are supplied in several forms: waxy solids, semi-solid pastes, and clear liquids, depending on the feedstock fatty acid composition and extent of acetylation. Commercial Myvacet-type products include a waxy solid (Type 5–00) for food coatings on non-refrigerated foods and a low-melting oil (Type 9–40) used as emulsifier and plasticizer.

4. Historical and Traditional Use

Unlike many botanical dietary supplements, acetoglycerides have no documented history of traditional herbal or ethnopharmacological use. Their development is entirely industrial and scientific in origin, dating primarily to the mid-twentieth century in the United States and Europe.

The foundational chemistry was established in the late 1940s and 1950s, driven by the food industry's need for functional fat substitutes and for agents capable of improving the preservation of perishable foods. Similar to other synthetic emulsifiers, the invention of AMG was driven by the food industry's need for functional substitutes for tallow and hydrogenated fats. Formal toxicological and absorption studies of acetostearin and acetoolein in animal models were published in the early-to-mid 1950s and formed the evidentiary basis for subsequent regulatory decisions worldwide.

Food coating applications represent the earliest documented practical use. Because of their melting and crystal properties, acetostearins were suggested as useful for coating food products such as meat, fish, cheese, and candy. Zabik and Dawson (1963) described the effect of acetylated monoglyceride coatings on cooked poultry during fresh and frozen storage. Luce (1967, Food Technology) reviewed various methods for the application of acetylated monoglycerides in coating food products such as meat cuts, poultry, sausages, sea foods, small fruits, and nuts.

In the bakery and confectionery industries, AMG was introduced during the same era as a texture and emulsification aid. Its stable alpha crystalline structure is the basis for its application in specialty fats, toppings, whippable emulsions, or cake mixes; in baked goods, mainly cakes, AMG is typically added to the liquid phase or batter, and its use in whipped cream, fillings, and frostings can help stabilize and extend shelf life, while in vegetable fat-based creams AMG improves whipping and foaming properties.

An early patent from the 1950s (U.S. Pat. No. 2,745,749) specifically identified acetylated monoglycerides obtained by acetylation of mixtures of glycerol monostearate and glycerol monopalmitate and described their potential food applications. Diacetyl triglycerides with melting points above room temperature but below body temperature were suggested as suitable coatings for edible products such as fruits, cheese, preserves, and frozen meats, and such acetylated monoglycerides were noted to have many potential food applications including coatings for meat products, candies, ice cream bars, and cheese.

An additional, later-emerging area of interest was the use of acetylated monoglycerides as pharmaceutical excipients and, separately, their investigation as agents potentially influencing blood lipid levels. A patent application (U.S. Pat. No. 4,272,548) claimed a process for lowering increased blood cholesterol and neutral fat in humans using acetylated monoglycerides, reflecting an area of exploratory research, though this application did not result in a formally approved pharmaceutical indication (see Scientific Evidence section).

5. Key Constituents and Active Compounds

Acetoglycerides are themselves the active compounds in applications ascribed to them; they are not complex botanical extracts containing multiple secondary metabolites. Their chemical identity is entirely defined by:

• The glycerol backbone, which provides the esterification template.
• Long-chain fatty acid moieties (typically C16–C18), whose chain length and degree of unsaturation determine melting point, texture, and digestibility. Stearic acid (C18:0), oleic acid (C18:1), palmitic acid (C16:0), and lauric acid (C12:0) are commonly encountered in different commercial grades.
• Acetyl groups (–OCOCH₃), introduced at one or two of the remaining free hydroxyl positions of the monoglyceride, which are responsible for the distinctive physical and emulsifying properties distinguishing acetoglycerides from ordinary monoglycerides.

The specific combination of these components in each commercial product is variable, which is why regulatory specifications describe ranges rather than fixed compositions. Purity specifications include the Reichert-Meissl value (a measure of volatile acid content) and the acid value. The food additive has a Reichert-Meissl value of 75–200 and an acid value of less than 6.

6. Mechanisms of Action

6.1 Physical and Emulsification Mechanisms

The introduction of acetyl groups into the monoglyceride structure modifies its crystalline state and polarity relative to unmodified monoglycerides and ordinary triglycerides. The stable alpha crystalline structure of AMG is responsible for its emulsifying properties mainly at higher temperatures. Acetylated monoglycerides (AMG) films display the exclusive characteristic of solidifying from the melting state to a flexible, wax-like solid, and elongation of the films can be as high as 800%, whereas most lipids in the solid state can be stretched to only about 102%.

The low HLB value (1.5) of AMG confers predominantly lipophilic character, which is why it functions not as a conventional oil-in-water emulsifier but rather as a stabilizer within fat phases, a plasticizer for edible coatings, and a crystal modifier in fat-based products. The emulsifying properties of AMG are improved when combined with other surfactants.

6.2 Gastrointestinal Hydrolysis and Metabolic Fate

The metabolic handling of acetoglycerides is well characterized in regulatory toxicology. Acetoglycerides are readily hydrolysed in the gastrointestinal tract and dealt with in the body in a manner similar to other glycerides. The ester bonds linking acetic acid and fatty acids to the glycerol backbone are cleaved by pancreatic and intestinal lipases, releasing acetic acid (a normal dietary component found in vinegar and fermented foods), long-chain fatty acids, and glycerol—all of which are ordinary nutrients subject to normal metabolic pathways.

Hydrolysis of E472a was demonstrated in various experimental systems, although the available data on absorption, distribution, metabolism, and excretion (ADME) were limited; the EFSA Panel assumed that E472a is extensively hydrolysed in the GI tract and/or pre-systemically after absorption into its individual hydrolysis products, which are all normal dietary constituents and are metabolised or excreted intact.

Animal lipolytic studies provided early mechanistic detail. Lipolytic studies in rats showed the presence of large amounts of free fatty acids but only traces of free acetic acid in the lipids isolated from the stomach after feeding acetoglycerides; ligation of the pylorus indicated a more rapid absorption of the acetic acid moiety by the stomach wall than of glycerol and monoacetin. This indicates that upon ingestion, acetoglycerides are rapidly hydrolysed at the gastric and intestinal levels, with the acetic acid component being absorbed very quickly via the stomach and the long-chain fatty acid component undergoing standard lymphatic chylomicron transport.

7. Scientific Evidence by Area of Use

7.1 Digestibility and Nutritive Value

Evidence type: Animal (rat) studies; no controlled human clinical trials.

The question of whether acetoglycerides are nutritionally equivalent to conventional dietary fats was addressed in a series of animal studies conducted in the 1950s. The acetooleins appear to be better absorbed than the acetostearins over a 4-hour test period in rats; however, the acetostearins are absorbed at about the same rate as conventional shortenings (Crisco) under the conditions of the experimental procedures; and the various acetoglycerides appear to be utilized by the rat in much the same way as natural fats.

The digestibility coefficients of acetoglycerides fed as 20% of the diet to rats varied between 94 and 99% depending on the composition of the mixture administered (Ambrose & Robbins, 1956b). However, a distinction was found between saturated and unsaturated variants: the digestibility coefficients obtained were approximately 99% for the acetooleins, 80 and 80.8% for the acetostearins melting at 30.7°C and 57°C respectively, and 85% for the acetostearin melting at 32.5°C.

There was no difference between test and control rat groups with regard to body-weight gain, food consumption, or food efficiency, except for the groups receiving stearins; only in the groups receiving diacetostearin was the coefficient of utilization markedly higher; results of examination of blood and urine were normal (Mattson et al., 1956).

These acetoglycerides were investigated during the 1950s and found to be digestible; feeding studies indicated that the nutritive value of mono- and diacetin fats were essentially the same in animals as those fed the corresponding conventional triglycerides (Mattson, F. H., et al., J. Nutr. 59: 277–285, 1956).

Strength of evidence: This body of evidence is exclusively preclinical (rat feeding studies from the mid-twentieth century). No controlled human digestibility trials of acetoglycerides as a dietary supplement have been identified in the available literature. The animal data nonetheless formed the basis for the conclusion by international regulatory bodies that the compound's breakdown products are ordinary dietary constituents with no special toxicological significance.

7.2 Potential Effects on Blood Lipids

Evidence type: Preclinical; one exploratory patent application; no human clinical trials identified.

A patent application (U.S. Pat. No. 4,272,548) described a process and composition based on the oral administration of acetylated monoglycerides for the purpose of lowering elevated blood cholesterol and neutral fat in humans. The preferred material described in this application was a completely acetylated monoglyceride produced from lard, administered orally. However, no peer-reviewed, published human clinical trial data supporting this application were identified in the authoritative literature reviewed. This patent-level claim should not be interpreted as evidence of an established pharmacological effect in humans.

7.3 Use as a Pharmaceutical Excipient / Drug Delivery Vehicle

Evidence type: Formulation science and preclinical studies; not a clinical health endpoint.

Acetylated monoglycerides have been investigated extensively as excipients in lipid-based drug delivery systems (LBDD). Acetylated monoglycerides consist of glycerol esterified with fatty acids at one of the three hydroxyl functions, with the other two hydroxyls replaced by acetyl moieties; they are sold in the United States under the tradename "Myvacet"; they are made by reacting fats with glycerine and triacetin; and by adjusting the degree of saturation of the monoglyceride and the degree of acetylation, different characteristics are obtained.

Their utility in pharmaceutical formulations arises from their ability to solubilize poorly water-soluble drugs, their acceptance in liquid crystalline phase systems, and their status as food-approved materials. A composition containing acetylated monoglycerides may have an active agent dispersed throughout the liquid crystalline phase, in either the water domain or the lipid domain; useful active agents include hydrophobic compounds, hydrophilic compounds, and amphiphilic compounds, particularly pharmaceutical agents; examples include vitamins, proteins and peptides, nucleic acids, growth promoters for wound treatment, and poorly water-soluble drugs.

Strength of evidence: The pharmaceutical excipient literature consists largely of formulation science, in vitro release studies, and preclinical (animal) bioavailability data. No clinical outcomes data specifically attributing a therapeutic benefit to acetylated monoglycerides themselves (as distinct from the drugs they carry) have been identified.

7.4 Food Preservation and Edible Coatings

Evidence type: Applied food science studies; this is a functional food ingredient application rather than a health supplement claim.

The most extensively documented area of applied use for acetoglycerides is as edible coatings for perishable foods. AMG films are mainly used for poultry and meat cuts to retard moisture loss during storage. Synthetic acetylated monoglycerides have been used with FDA approval in edible films for meat, fish, and poultry; originally, lipid coatings were applied by simply pouring molten paraffin or wax over citrus fruits. Their film-forming property arises from the ability of the alpha crystalline form to set into a continuous, flexible, wax-like barrier. The acetylated monoacylglycerols have film-forming properties and are useful in various food applications as coating agents.

7.5 Baking and Emulsification

Evidence type: Applied food technology; not clinical research.

Acetylated monoglycerides act as volume enhancers in baked goods, consistency enhancers in milk products, and viscosity enhancers in chocolate products. In fillings for pastries, cakes, and confectionery, acetylated monoglycerides act as emulsifiers and stabilizers; they help in achieving a smooth and creamy consistency, ensuring uniform distribution of ingredients, and contribute to the stability of fillings, preventing separation or weeping and enhancing the overall sensory experience.

8. Body Systems and Health Areas

The following organ systems and physiological areas have been connected to acetoglycerides in the reviewed scientific and regulatory literature. The nature of the association is specified for each.

• Gastrointestinal system: Acetoglycerides are hydrolysed in the GI tract by lipases; their metabolic products (acetic acid, glycerol, fatty acids) are absorbed and metabolised via normal pathways. Acetoglycerides are readily hydrolysed in the gastrointestinal tract and dealt with in the body in a manner similar to other glycerides. This is a characterised metabolic fate, not a claimed therapeutic benefit.
• Lipid metabolism: Animal data confirm that acetoglycerides are metabolized similarly to conventional dietary fats at normal intake levels. The various acetoglycerides appear to be utilized by the rat in much the same way as natural fats. Exploratory patent literature proposed a lipid-lowering application in humans, but this has not been validated in published clinical trials.
• Integumentary system / food surfaces: As edible coatings, acetoglycerides form moisture barriers protecting food products. Their film-forming and barrier properties have been studied in applied food science, particularly for poultry, meat, fruits, and nuts.

9. Dosage Forms and Reported Dosages

In food applications, the food additive is used at a level not in excess of the amount reasonably required to produce its intended effect in food, or in food processing. This is the standard FDA "quantum satis" (q.s.) principle for this additive category; no maximum numeric food-use level is specified in 21 CFR 172.828.

In digestibility studies, absorption of acetoolein or acetostearin, given as 20% of the diet, was studied in groups of 10 adult male rats. Groups of 10 male weanling rats received diets containing 25% of either stearin, olein, diacetostearin, or diacetoolein, and additional groups received 50% olein or diacetoolein for 8 weeks, or 15% acetoolein for 12 weeks. These are experimental dietary loading doses in rodents, not dosages intended for human consumption.

In toxicology studies in rats, no toxic effects were observed in rats receiving single oral doses of 4 g/kg body weight, nor in rats consuming diets containing 5%, 10%, or 20% acetostearin for fourteen weeks, nor in rats on diets containing up to 4% acetostearin or 1% aceto-olein for fifty-seven weeks.

As a pharmaceutical excipient in drug delivery formulations, acetylated monoglycerides are incorporated at levels determined by the specific formulation design; no clinical dosage range specific to acetylated monoglycerides as a supplement or therapeutic agent has been identified in the reviewed literature. In cosmetic and topical products, acetylated monoglycerides have historically appeared under trade names such as Dermatex and Skintex, though specific dose recommendations are absent from the authoritative sources reviewed.

10. Safety, Regulatory Status, and Notable Considerations

10.1 Regulatory Status

Acetylated monoglycerides are a class of chemical compounds used as food additives and as plasticizers; as a food additive they have the E number E472a and are used as an emulsifier and in edible coatings. Under U.S. law (21 CFR 172.828), the food additive acetylated monoglycerides may be safely used in or on food in accordance with the prescribed conditions.

International regulatory acceptance is well established. The JECFA designation is INS 472a with functional class "food additive / emulsifier," and the substance has been evaluated by JECFA since 1965–1966. The EFSA Panel on Food Additives and Flavourings (FAF) provided a scientific opinion re-evaluating the safety of acetic acid esters of mono- and diglycerides of fatty acids (E472a–f) as food additives in 2020; all substances had been previously evaluated by the Scientific Committee for Food (SCF) and by JECFA.

10.2 Acceptable Daily Intake

The EFSA FAF Panel considered that as there are no relevant adverse effects reported for E472a, b, c and since none of their hydrolysis products raise any safety concerns, presently there is no need for a numerical ADI for E472a, b, c. An ADI of "not specified" or "not limited" reflects the highest level of confidence in safety: it means that no quantitative upper limit needs to be established because the totality of available evidence does not identify a level of concern. All substances of the group E472a–f have been evaluated by the SCF, and an ADI "not specified" was established for all substances except E472e (SCF, 1978).

No adverse effects relevant for humans have been identified from the toxicological database available for E472a–f; the Panel considered that there is no need for a numerical acceptable daily intake (ADI) for E472a, b, c. Exposure estimates were calculated for all food additives individually, and considering the exposure estimates, there is no safety concern at their reported uses and use levels.

10.3 Animal Toxicology Data

Results of studies on the toxicity of two acetoglycerides (acetostearin and aceto-olein) administered by various routes to albino rats, rabbits, and guinea pigs showed no toxic effects in rats receiving single oral doses of 4 g/kg body weight, nor in rats consuming diets containing 5%, 10%, or 20% acetostearin for fourteen weeks, nor in rats on diets containing up to 4% acetostearin or 1% aceto-olein for fifty-seven weeks; no blood changes or major histopathological visceral damage were observed in rats used for the subacute and chronic toxicity experiments.

One important historical finding at high dietary loads warrants mention: testicular atrophy due to an increased requirement for Vitamin E, and foreign body reaction in adipose tissue due to overloading with saturated fatty acids, were observed with high-dose levels of acetostearin; however, such effects are very likely to be irrelevant considering the levels of use of these compounds. The JECFA evaluation attributed these high-dose effects to indirect, non-specific mechanisms related to excessive dietary fat loading rather than to inherent toxicity of the acetoglyceride moiety itself.

The digestibility studies are only of limited value since the inclusion of materials of this sort in an adequate quantity of lipid fat occurring naturally in the diet ensures satisfactory absorption; dietary loads of a food additive in excess of 10% are of little value in the assessment of safety-in-use, as many irrelevant effects may occur, such as observed with high-dose levels of acetostearin.

10.4 Metabolic Safety Rationale

The safety conclusion rests substantially on the metabolic fate of the compound. Evaluation is based on the biochemical and metabolic studies because the breakdown products are normal dietary constituents. Because hydrolysis liberates only acetic acid, fatty acids, and glycerol—all of which are ordinary food constituents with well-characterized metabolic pathways—there is no basis for anticipated accumulation or organ toxicity at levels consistent with food use.

10.5 Potential Concerns Related to Manufacturing and Raw Materials

The EFSA re-evaluation noted a concern not unique to acetoglycerides but shared with the broader class of glyceride-based food additives. The EFSA Panel noted that epichlorohydrin may be present in mono- and di-glycerides of fatty acids from the manufacturing process of glycerol, as well as glycidol, which can also be used as starting material for the manufacturing process of monoglycerides of fatty esters; the Panel considered that the presence of epichlorohydrin and/or glycidol in such additives would need further assessment as their presence could raise a safety concern. This concern relates to process impurities potentially arising in the intermediate glycerol production or glycerolysis step, not to the acetoglyceride molecule itself.

Additionally, the EFSA ANS Panel noted that the production of 3-MCPD (3-monochloropropane-1,2-diol) and glycidyl esters (GEs) is increased upon heating above 160°C and 200°C respectively, as demonstrated in various model food heating tests conducted with mono- and diglycerides of fatty acids; and that GEs may be formed during the dehydration of monoglycerides. These process-related contaminants are subject to ongoing regulatory monitoring.

10.6 Source-Derived Considerations

Because acetoglycerides can be derived from either animal fats (including lard) or vegetable oils, the source of the fat used in production is relevant to individuals observing specific dietary restrictions (e.g., halal, kosher, or vegan requirements). The physical and chemical properties of the final product may also differ depending on whether animal or vegetable feedstocks are used, owing to differences in the fatty acid profiles of those source materials. The product may contain free glycerol and free fatty acids as minor constituents, which are not toxicologically significant but are relevant to compositional specifications.

11. Distinction Between Food Additive and Dietary Supplement Use

It is important to draw a clear distinction between the well-documented use of acetoglycerides as approved food additives (emulsifiers, coating agents, plasticizers in foods) and any claims that might be made about them as standalone dietary supplements with specific health effects. Some preliminary studies and anecdotal reports suggest that acetylated glycerides can support digestive processes and may play a role in modulating lipid metabolism, although robust clinical trials specifically evaluating acetoglyceride are still lacking. The mechanistic rationale for health-related claims derives from the fact that the hydrolysis products include acetic acid (associated with various metabolic effects in some research contexts) and fatty acids of nutritional interest; however, no published, peer-reviewed, controlled human clinical trials have specifically examined oral supplementation with acetoglycerides as a health intervention. The evidence base reviewed by JECFA, EFSA, and the U.S. FDA specifically addresses safety at food-use levels, not efficacy for any therapeutic purpose.

References

• JECFA/FAO/WHO – Acetic Acid and Fatty Acid Esters of Glycerol (FAO Nutrition Meetings Report Series 40abc, 1967)
• JECFA/WHO – Acetic and Fatty Acid Esters of Glycerol (WHO Food Additives Series 5)
• WHO/JECFA Database – Acetic Acid Esters of Mono- and Diglycerides (E472a)
• EFSA FAF Panel – Re-evaluation of E472a–f as food additives (EFSA Journal 2020, PMC full text)
• EFSA Journal 2020 – Re-evaluation of acetic acid, lactic acid, citric acid, tartaric acid, mono- and diacetyltartaric acid, mixed acetic and tartaric acid esters of mono- and diglycerides of fatty acids (E 472a–f)
• EFSA Journal 2025 – Re-evaluation of citric acid esters of mono- and diglycerides of fatty acids (E 472c) in foods for infants below 16 weeks of age
• U.S. FDA – 21 CFR § 172.828: Acetylated Monoglycerides (eCFR)
• Wikipedia – Acetylated Monoglyceride
• Gunstone, F.D. – Lipid Glossary 2 (Skinident/Sheffield Academic Press)
• BAKERpedia – Acetylated Monoglycerides (AMG)
• American Society of Baking – Acetylated Monoglycerides (AMG)
• Ambrose & Robbins – Studies on the Toxicity of Acetoglycerides (ResearchGate)
• Ambrose & Robbins – Studies on Comparative Absorption and Digestibility of Acetoglycerides (Journal of Nutrition, ScienceDirect)
• Poultry Science – An Edible Acetylated Monoglyceride Coating for Poultry Meat Preservation (Oxford Academic)
• U.S. Patent 5,516,536 – Cheese Coating Composition and Method for Producing a Protective Coating on Cheese
• U.S. Patent 4,272,548 – Process for the Lowering of Increased Levels of Cholesterol and Neutral Fat in the Blood of Humans
• U.S. Patent 7,510,584 – Acetylated Wax Compositions and Articles Containing Them
• U.S. Patent 6,159,933 – Emulsion Preconcentrate Comprising a Cyclosporin, Propylene Carbonate, and Glycerides
• EFSA ANS Panel – Re-evaluation of mono- and di-glycerides of fatty acids (E 471) as food additives (ResearchGate)